Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MBX

MBX Biosciences, Inc.

CIK 0001776111 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$65.71
↑ 3.97 (6.43%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$3.13B
P/E Ratio
-36.11
EPS
-2.38
Dividend Yield
Not covered
52W Position
99%
Beta
1.56

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
7.14
P/S
Not covered
EV/Revenue
Not covered
ROE
-19.8%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 99%
$9.63$66.55

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$86.97M
Total Assets
$385.14M
Free Cash Flow
-$81.88M

Recent news